| # | Drug | Count |
|---|---|---|
| 0 | NALTREXONE | 15 |
| 1 | ARIPIPRAZOLE | 11 |
| 2 | ARIPIPRAZOLE ORAL | 11 |
| 3 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 11 |
| 4 | ESCITALOPRAM | 10 |
| 5 | QUETIAPINE | 9 |
| 6 | ESCITALOPRAM OXALATE | 8 |
| 7 | ESCITSLOPRAM | 8 |
| 8 | GABAPENTIN | 7 |
| 9 | PREGABALIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DRS LIDOCAINE 5% CREAM | 1 | 0.0222 |
| 1 | DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 1 | 0.0019 |
| 2 | OLANZAPINE AND SAMIDORPHAN L-MALATE | 1 | 0.0006 |
| 3 | LEVOMILNACIPRAN HYDROCHLORIDE | 1 | 0.0005 |
| 4 | NALTREXONE | 15 | 0.0005 |
| 5 | PRAZOSIN | 3 | 0.0005 |
| 6 | AMISULPRIDE | 2 | 0.0003 |
| 7 | HYDROXYZINE PAMOATE | 1 | 0.0003 |
| 8 | LEVALBUTEROL TARTRATE | 1 | 0.0003 |
| 9 | LOMITAPIDE MESYLATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 21 |
| 1 | Atypical Antipsychotic [EPC] | 18 |
| 2 | Anti-epileptic Agent [EPC] | 5 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 4 | Integrin Receptor Antagonist [EPC] | 4 |
| 5 | Mood Stabilizer [EPC] | 4 |
| 6 | Sympathomimetic-like Agent [EPC] | 3 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| 8 | Vitamin C [EPC] | 3 |
| 9 | Antiarrhythmic [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 2 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 4 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 5 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | Sympathomimetic-like Agent [EPC] | 3 | 0.0001 |
| 8 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |